Workflow
CTV
icon
Search documents
TTD Declines 23% in a Year: Continue to Hold or Sell the Stock?
ZACKS· 2025-07-10 15:05
Key Takeaways TTD shares have dropped nearly 23.3% over the past year, underperforming broader indices. Macro volatility and fierce competition from Amazon and Google remain concerns for TTD. Heavy reliance on CTV and North America limits upside amid declining investor confidence.The Trade Desk (TTD) , a well-known name in the programmatic advertising space, has seen its stock take a significant hit. The stock price has declined 23.3% over the past year,  underperforming the Zacks Internet Services indust ...
神州细胞收盘下跌2.74%,滚动市盈率337.77倍,总市值342.91亿元
Jin Rong Jie· 2025-07-09 11:03
从行业市盈率排名来看,公司所处的生物制品行业市盈率平均74.16倍,行业中值44.75倍,神州细胞排 名第73位。 截至2025年一季报,共有13家机构持仓神州细胞,其中其他7家、基金6家,合计持股数33127.91万股, 持股市值134.96亿元。 7月9日,神州细胞今日收盘77.0元,下跌2.74%,滚动市盈率PE(当前股价与前四季度每股收益总和的 比值)达到337.77倍,总市值342.91亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13神州细胞337.77306.30-84.73342.91亿行业平均 74.1659.3810.22203.06亿行业中值44.7540.852.9483.84亿1西藏药业11.7911.302.90118.84亿2长春高新 18.8516.031.76414.10亿3川宁生物20.1319.213.28268.95亿4安科生物20.9820.723.59146.51亿5英诺特 21.0416.712.0041.25亿6上海莱士22.9420.941.41459.35亿7派林生物23.7322.682.11169.08亿8华兰生物 25.3326.532 ...
T Optimizes Portfolio With Strategic Divestiture: Will it Fuel Growth?
ZACKS· 2025-07-04 15:11
Core Insights - AT&T has completed the divestiture of its remaining 70% stake in DIRECTV, allowing the company to focus on its core business and reduce debt [1][3][7] Group 1: Company Strategy and Financials - The divestiture of DIRECTV is a strategic move for AT&T, enabling the company to concentrate on its primary growth areas, particularly 5G wireless and fiber network expansion [3][7] - AT&T has received $19 billion from previous TPG distributions and is set to receive an additional $7.6 billion by 2029, which will help lower its debt burden and improve liquidity [3][7] - The company's shares currently trade at a price/book ratio of 13.27 forward earnings, which is lower than the industry average of 13.53 but above its historical mean of 10.67 [8] Group 2: Industry Context and Competition - AT&T's venture into the media business, including the acquisition of DIRECTV and WarnerMedia, faced challenges due to declining subscriptions and competition from streaming services like Netflix and Amazon [2][5] - The competitive landscape includes major players like Charter Communications and Comcast, both of which are investing in expanding their network infrastructure and facing similar challenges in retaining cable TV subscribers [4][5] Group 3: Performance Metrics - Over the past year, AT&T's stock has gained 51.8%, outperforming the Wireless National industry's growth of 26.7% [6] - Earnings estimates for 2025 and 2026 have remained unchanged over the past 60 days, indicating stability in the company's financial outlook [9]
TTD Global Momentum Increases as International Growth Overtakes U.S.
ZACKS· 2025-06-23 13:56
Key Takeaways TTD's international growth beat North America for the ninth straight quarter despite lower ad spend share. CTV remains a key driver, with over 90M households reached and strong traction worldwide. Two-thirds of clients now use Kokai, cutting costs and boosting efficiency ahead of full adoption this year.In the last reported quarter, The Trade Desk’s (TTD) “International growth again outpaced North America for the ninth quarter in a row,” marking a major milestone. While North America account ...
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast
Globenewswire· 2025-06-18 17:41
MORRISTOWN, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- via IBN – Authentic Holdings, Inc. (OTC PINK: AHRO) today announced a landmark licensing agreement between one of its wholly-owned subsidiaries, Maybacks Global Entertainment, LLC, https://www.maybackstv.com/ and Swerve TV https://swerve.tv/ which has been validated by a highly successful inaugural live broadcast. The partnership's first event, a live stream of the legendary "Ring of Combat" promotion from the Tropicana in Atlantic City this past Friday J ...
The Trade Desk Expands CTV Ad Partnership With HOY in Hong Kong
ZACKS· 2025-06-18 15:25
Key Takeaways The Trade Desk teams with HOY to launch programmatic CTV ad trading across the Hong Kong media market. HOY integrates UID2 and OpenPath to boost targeting, efficiency and transparency for digital advertisers. TTD sees HOY's adoption of advanced tools as pivotal to building a modern, high-performance ad ecosystem.The Trade Desk, Inc. (TTD) has announced an expanded partnership with HOY, the media platform operated by i-CABLE Communications Limited. Through this collaboration, HOY will enable ...
Roku (ROKU) Surges 10.4%: Is This an Indication of Further Gains?
ZACKS· 2025-06-17 14:16
Roku (ROKU) shares rallied 10.4% in the last trading session to close at $82.17. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.3% gain over the past four weeks.The uptick in share price came after the companu announced partnership with Amazon Ads to launch a new integration that could reshape how advertisers reach Connected TV (CTV) audiences. Through Amazon DSP, advertisers can now access an estimated 80 ...
The Trade Desk Tanks 47% in Six Months: Should You Avoid TTD Stock?
ZACKS· 2025-06-06 13:40
Key Takeaways The Trade Desk has fallen 47.2% in six months, sharply underperforming peers and broader indices. Macroeconomic uncertainty, rising costs, and fierce competition are weighing on TTD's growth prospects. TTD's high valuation and weak international presence limit upside amid declining investor confidence.The Trade Desk (TTD) shares have plunged 47.2% in the past six months, raising tough questions about its near-term trajectory. Though volatility has affected broader indices in the past couple ...
神州细胞: 神州细胞前次募集资金使用情况报告
Zheng Quan Zhi Xing· 2025-06-05 13:14
证券代码:688520 证券简称:神州细胞 公告编号:2025-023 北京神州细胞生物技术集团股份公司 前次募集资金使用情况报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 前次募集资金基本情况 (一)首次公开发行股票 根据中国证券监督管理委员会于 2020 年 4 月 29 日出具的证监许可2020815 号文《关于同意北京神州细胞生物技术集团股份公司首次公开发行股票注册的批 复》,北京神州细胞生物技术集团股份公司(以下简称"公司"或"本公司")获 准向境内投资者首次公开发行人民币普通股 5,000.00 万股,发行价格为每股人民 币 25.64 元。本次公开发行股票募集资金总额为人民币 1,282,000,000.00 元,扣 除承销费人民币 60,971,940.00 元(不含增值税)后,实际收到募集资金人民币 值税)后,实际募集资金净额为人民币 1,201,173,211.41 元。前述募集资金于 2020 年 6 月 15 日到位,经普华永道中天会计师事务所(特殊普通合伙)予以验证并 出具了普华永道中 ...